Position in EBS
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$1,465,938
+$13,995 QoQ
Shares Held
174,933
0.0% QoQ
Ownership
0.341%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#40
of 193 holders
Holding Since
Mar 2021
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in EBS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026WOLVERINE ASSET MANAGEMENT LLC holds $11,280,730 across 7 Drug Manufacturers - Specialty & Generic names. EBS ranks #2 (13.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HIMS |
Hims & Hers Health, Inc.
|
251,619 | $8,723,630 | |
| 2 | EBS |
Emergent BioSolutions Inc.
This page
|
174,933 | $1,465,938 | |
| 3 | PRGO |
PERRIGO Co plc
|
61,551 | $639,514 | |
| 4 | BHC |
Bausch Health Companies Inc.
|
73,094 | $360,353 | |
| 5 | ZTS |
Zoetis Inc.
|
1,270 | $91,262 | |
| 6 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1 | $33 | |
| 7 | ALVO |
Alvotech
|
24,165 | $0 |
All Filings in EBS
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,465,938 | 174,933 | Shares | Defined | 2026-08-10 | |
| 2026-03-31 | $1,451,943 | 174,933 | Shares | Defined | 2026-05-04 | |
| 2025-12-31 | $2,162,171 | 174,933 | Shares | Defined | 2026-02-02 | |
| 2025-09-30 | $1,542,909 | 174,933 | Shares | Defined | 2025-10-28 | |
| 2025-06-30 | $1,116,072 | 174,933 | Shares | Defined | 2025-08-04 | |
| 2025-03-31 | $662,578 | 136,333 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $1,303,343 | 136,333 | Shares | Defined | 2025-02-03 | |
| 2021-09-30 | $134,938 | 2,695 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $169,758 | 2,695 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $608,653 | 6,551 | Shares | Defined | 2021-05-13 | |
| No filing history on record for this holder in this stock. | ||||||